In 2019, as Pfeiffer's lung function deteriorated and she went on a wait list for a double lung transplant, the FDA approved a new drug for cystic fibrosis called Trikafta. "It's just completely ...

Along with hundreds of other people with CF, I have also become a parent since Trikafta hit the market. The CF community’s baby-boom we’ve all worked toward has happened thanks to this drug.

Elexacaftor, tezacaftor, ivacaftor; 80mg/40mg/60mg with ivacaftor 59.5mg; 100mg/50mg/75mg with ivacaftor 75mg; packets. Elexacaftor and tezacaftor bind to different sites on the CFTR protein and ...

The Prescription Drug Affordability Board unanimously voted against declaring Trikafta — a drug to treat cystic fibrosis — unaffordable at a meeting Friday morning. If the state’s new board ...

Trikafta corrects the misshapen protein that causes cystic fibrosis; this molecular tweak thins mucus in the lungs so it can be coughed up easily. In a matter of hours, patients who took it began ...

“The development of Trikafta has been one of the most phenomenal ... can increase life expectancy from around 30 to more than 80 years 2. “I hear almost every day from people who were really ...

TRIKAFTA has had a transformative impact on tens of thousands of people living with cystic fibrosis," said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical ...

Lacking access to an effective-yet-costly cystic fibrosis (CF) therapy from Vertex Pharmaceuticals, patients and activists in four countries are attempting to take matters into their own hands.

Since its Food and Drug Administration (FDA) approval in 2019 and subsequent EMA approval in 2020, Vertex Pharmaceuticals’ Trikafta (ETI and ivacaftor) has revolutionised CF care, with global ...

Vertex Pharmaceuticals (VRTX) announced the U.S. Food and Drug Administration has approved the expanded use of Trikafta for the treatment of people with cystic fibrosis ages 2 and older who have ...

His lung function dropped to 50 per cent. All that began to change in November, 2021, when he swallowed his first dose of Trikafta, a life-altering medication for people with cystic fibrosis ...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that data on TRIKAFTA ® (elexacaftor/tezacaftor/ivacaftor and ivacaftor ...